Back
Design Therapeutics Stock Price Chart
Sponsored
DSGN
Sponsored
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Buy
52
DSGN
Design Therapeutics
Last Price:
5.95
Seasonality Move:
-1.4%
7 Day Trial
ALL ACCESS PASS
$
7
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Design Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.01 | Buy |
20-day SMA: | 5.2 | Buy |
50-day SMA: | 5 | Buy |
200-day SMA: | 3.85 | Buy |
8-day EMA: | 5.19 | Buy |
20-day EMA: | 5.14 | Buy |
50-day EMA: | 4.98 | Buy |
200-day EMA: | 4.38 | Buy |
Design Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 59.42 | Buy |
Chaikin Money Flow: | 68631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.91 - 5.67) | Buy |
Bollinger Bands (100): | (3.79 - 5.23) | Buy |
Design Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.65 while DSGN 8-day simple moving average is 5.01, which is a Buy signal.
- The stock price of DSGN is 5.65 while Design Therapeutics 20-day SMA is 5.20, which makes it a Buy.
- Design Therapeutics 50-day simple moving average is 5.00 while DSGN share price is 5.65, making it a Buy technically.
- DSGN stock price is 5.65 and Design Therapeutics 200-day simple moving average is 3.85, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Buy
52
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Buy
The current Design Therapeutics [DSGN] share price is $5.65. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Design Therapeutics Stock Info
Market Cap:
319.91M
Price in USD:
5.65
Share Volume:
123.45K
Design Therapeutics 52-Week Range
52-Week High:
6.91
52-Week Low:
1.96
Buy
52
Design Therapeutics (DSGN)
is a Buy
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 5.65 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is not overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.65 while DSGN 8-day exponential moving average is 5.19, which is a Buy signal.
- The stock price of DSGN is 5.65 while Design Therapeutics 20-day EMA is 5.14, which makes it a Buy.
- Design Therapeutics 50-day exponential moving average is 4.98 while DSGN share price is 5.65, making it a Buy technically.
- DSGN stock price is 5.65 and Design Therapeutics 200-day simple moving average is 4.38, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 59.42, which suggest Design Therapeutics is overbought
- The Bollinger Bands (25) for Design Therapeutics is (4.91 - 5.67), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (3.79 - 5.23), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.